Suppression of the Neoplastic Phenotype
The concept that neoplasia results from an accumulation of somatic mutations in the tumour lineage is heuristically extremely useful. Strong support for this hypothesis has been provided by the demonstration that suitably altered proto-oncogenes can induce a neoplastic phenotype when introduced into normal recipient cells. However, activated oncogenes that behave in this phenotypically “dominant” fashion have been detected so far in only a minority of tumours and therefore the genetic basis of neoplasia in most cancers remains obscure. There are at least four explanations for the frequent failure to implicate positively acting oncogenes.
KeywordsCell Hybrid Somatic Cell Hybrid Neoplastic Phenotype Avian Sarcoma Virus Phenotypic Reversion
Unable to display preview. Download preview PDF.
- Anders F (1983) The biology of an oncogene, based upon studies in neoplasia in Xiphophorus. In: Neth R, Gallo R (eds) Modern trends in human leukemia 5. Springer, Berlin Heidelberg New York, p 186Google Scholar
- Griegel S, Traub O, Willecke K, Schafer R Suppression and reexpression of transformed phenotype in hybrids of Ha-ras 1 transformed Rat-1 cells and early passage rat embryo fibroblasts. SubmittedGoogle Scholar
- Wyke JA, Beamand JA, Varmus HE (1980) Factors affecting phenotypic reversion of rat cells transformed by avian sarcoma virus. Cold Spring Harbor Symp Quant Biol XLIV: 1065–1075Google Scholar